Retia Medical Receives FDA 510(k) Clearance for Argos Infinity™, Expanding Cardiovascular Intelligence Across High-Risk Surgical and Critical Care Environments
WHITE PLAINS, NEW YORK, UNITED STATES — February 16, 2026 — Retia Medical today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Argos Infinity™, the company’s cardiovascular intelligence software platform designed for high-risk surgical... Read More →
InVera Medical achieves European CE Mark approval for new vein infusion device
GALWAY, Ireland, Feb. 13, 2026 /PRNewswire/ — InVera Medical, an Irish medical technology company, has received European regulatory approval for a new minimally invasive device designed to help physicians deliver treatment more effectively to diseased leg veins, including varicose veins.... Read More →
Crux of Medtech: A New Vital Sign for Heart Failure with Filip Peters, CEO of Acorai
In this episode of the Crux of Cardio, host Jordan Bergen sits down with Filip Peters, Co-founder and CEO of Acorai, to unpack how his team is building a non-invasive device that reads the pressures inside the heart, using machine... Read More →
Australian breast cancer innovators close $27M private funding round featuring OncoRes Medical
PERTH, Australia–(BUSINESS WIRE)–OncoRes Medical today announced it has closed an AUD $27M private funding round (‘the Funding round’) to progress clinical development and regulatory milestones for its Quantitative Micro-Elastography (QME) Imaging System, Elora™. The Funding round included a cornerstone investment... Read More →
Entirety Biomedical Closes $1.2 Million Seed Financing to Advance Absorbable Magnesium Implants for Orthopedic Fixation
DETROIT, Feb. 11, 2026 (GLOBE NEWSWIRE) — Entirety Biomedical, a Michigan-based medical device startup developing bioabsorbable implant systems with its proprietary Curasorb technology, today announced the closing of a $1.2 million Seed financing round to advance toward first-in-human clinical trials.... Read More →
Neuspera Medical announces milestone case of traditional sacral neuromodulation (SNM) system removed and replaced with the company’s integrated SNM system for urinary urge incontinence
Patient Struggled with SNM Battery Pain and Complications; Reports Full Complication Relief Following Implant of Neuspera’s SNM Therapy New Patient Registry to Track Outcomes of SNM to iSNM Procedures SAN JOSE, Calif., Feb. 10, 2026 /PRNewswire/ — Neuspera® Medical, Inc.,... Read More →
Featuring Newrotex: Could this spider’s silk help repair nerves?
Scientists are using spider silk to help develop surgical devices for nerve regeneration. “It acts like a scaffold for nerves to grow along like a rose on a trellis,” Dr Alex Woods explains, holding threads of silk worthy of Spider-man.... Read More →
Leadoptik reports first-in-human use of lung biopsy tech
Leadoptik today announced the successful first-in-human clinical use of its FDA-cleared Last Inch Assessment (LIA) system, the company tells MassDevice. The first-in-human use took place at the University of Chicago Medical Center. It comes on the heels of FDA 510(k)... Read More →
Medtronic advances its innovation strategy with intent to acquire CathWorks
GALWAY, Ireland, Feb. 3, 2026 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will exercise its option to acquire CathWorks, a privately held medical device company, which aims to transform how coronary artery disease... Read More →
Tim Sweeney, Co-Founder and CEO of Inflammatix, Joins Sepsis Alliance Board of Directors
Sepsis Alliance, the leading patient advocacy organization dedicated to saving lives and reducing suffering by improving sepsis awareness and care, is pleased to announce that Tim Sweeney, MD, PhD, has joined its Board of Directors. Dr. Sweeney is cofounder and... Read More →